UBS Group’s Dermata Therapeutics DRMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.2K | Buy |
|
|||||
|
2025
Q1 | $75.9K | Buy |
|
|||||
|
2024
Q4 | $18.7K | Buy |
|
|||||
|
2024
Q3 | $2.46K | Sell |
|
|||||
|
2024
Q2 | $4.08K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $139 | Sell |
|
|||||
|
2023
Q2 | $11.6K | Buy |
|
|||||
|
2023
Q1 | $4.44K | Buy |
|
|||||
|
2022
Q4 | $15.3K | Buy |
|
|||||
|
2022
Q3 | $8K | Buy |
|
|||||
|
2022
Q2 | $7K | Buy |
|
|||||
|
2022
Q1 | $5K | Buy |
|
|||||
|
2021
Q4 | – | Hold |
|
|||||
|
2021
Q3 | – | Hold |
|